Hosted on MSN
Cracking prostate cancer's code: An enzyme's central role in controlling subtypes and improving therapeutic response
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at EPFL, and Eneda Toska at Johns Hopkins University have identified the enzyme ...
Fred Hutch researchers show in recent study how aggressive prostate cancer shapeshifts from a form that is treatable with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results